{"id":"W2988036010","doi":"10.1182/blood-2019-122970","title":"Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Placebo; Apixaban; Post-hoc analysis; Randomized controlled trial; Chemotherapy; Cancer; Proportional hazards model; Surgery; Clinical endpoint; Warfarin; Confidence interval; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01145876,0.002310165,0.006996497,0.0005597248,0.0004198952,0.001687989,0.001300974,0.001310683,0.007574796],"category_scores_gemma":[0.01274206,0.0005366463,0.0134838,0.0004580423,0.0008051674,0.001973046,0.001058639,0.004204641,0.0007052554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007314511,"about_ca_system_score_gemma":0.0009758887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000681225,"about_ca_topic_score_gemma":0.0009389673,"domain_scores_codex":[0.9931784,0.004540601,0.0004038698,0.0008503962,0.0004174585,0.0006093125],"domain_scores_gemma":[0.9872212,0.008762286,0.001467004,0.001238922,0.0005705454,0.0007401453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9480569,0.001085552,0.005248312,0.001347352,0.03350414,0.0001542814,0.00005633235,0.001445599,0.0009920812,0.0002747346,0.002134116,0.005700492],"study_design_scores_gemma":[0.6577001,0.1596289,0.05812116,0.0003930463,0.09438238,0.0005159494,0.0002511989,0.01626219,0.003759796,0.002235144,0.006473406,0.0002768059],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761689,0.01079429,0.002122049,0.0009364984,0.001509582,0.001339925,0.004373477,0.0001146091,0.00264064],"genre_scores_gemma":[0.9854046,0.001805893,0.001468036,0.00093988,0.001223206,0.001960159,0.004576529,0.00009963584,0.002522061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01145876,"threshold_uncertainty_score":0.0606004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007824736861508114,"score_gpt":0.2392830430493093,"score_spread":0.2314583061878012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}